INVO Fertility, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INVO Fertility, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-09-30 was $3.75M.
- INVO Fertility, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was -$178.67K, a 190.68% decline year-over-year.
- INVO Fertility, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $197.03K.
- INVO Fertility, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-12-31 was $250.00K.
- INVO Fertility, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $5.75M, a 1385.39% increase from fiscal 2024.
- INVO Fertility, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $387.03K.
- INVO Fertility, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $1.49M, a 2.89% increase from fiscal 2020.
- INVO Fertility, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $1.45M, a 508.16% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-12-31 | $5.75M 10-K · filed 2026-06-02 | |
| 2025-09-30 | $3.75M 10-K · filed 2026-06-02 | |
| 2025-06-30 | -$178.67K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $387.03K 10-K · filed 2026-06-02 | |
| 2024-06-30 | $197.03K 10-Q · filed 2025-11-17 | |
| 2021-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $1.49M 10-K · filed 2023-04-17 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | |
| 2021-03-31 | $1.24M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.45M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $238.72K 10-K · filed 2021-03-30 | |
| 2019-06-30 | $185.00K 10-Q · filed 2020-11-16 | |
| 2019-03-31 | $53.72K 10-Q · filed 2020-11-16 | |
| 2018-12-31 | $211.08K 10-K · filed 2020-03-30 | |
| 2017-12-31 | $57.94K 10-K · filed 2019-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |